Ending cancer for life. For over 140 years, this bold mission has guided Memorial Sloan Kettering Cancer Center as it helps patients and families confront one of life’s greatest challenges: cancer. But today, the ability to continue this vital work is threatened — not by scientific or medical limitations, but by the business practices of health insurers.

Imagine being one of the world’s leading cancer hospitals, renowned for life-saving treatments and unmatched patient outcomes and learning that health insurance companies reimburse you nearly 34% less than other institutions with inferior results. That’s the reality MSK faces in its ongoing contract negotiations with Anthem Blue Cross Blue Shield, despite MSK’s record of reducing hospitalizations, lowering overall treatment costs, and improving survival rates.

Recent healthcare pricing transparency laws have exposed a startling truth: Anthem pays significantly higher rates to other New York hospitals for cancer care, even though MSK consistently delivers better outcomes, including up to a 70% improvement in survival rates depending on the cancer stage. To........

© The Leader